A long-term time course of colorimetric assessment of the effects of imatinib mesylate on skin pigmentation: a study of five patients
2007-01-01 Brazzelli, V; Prestinari, F; Barbagallo, T; Rona, C; Orlandi, E; Passamonti, Francesco; Locatelli, F; Zecca, M; Villani, S; Borroni, G.
Platelet size distinguishes between inherited macrothrombocytopenias and immune thrombocytopenia.
2009-01-01 Noris, P; Klersy, C; Zecca, M; Arcaini, L; Pecci, A; Melazzini, F; Terulla, V; Bozzi, V; Ambaglio, C; Passamonti, Francesco; Locatelli, F; Balduini, C. L.
Nongastric marginal zone B-cell lymphoma of MALT: prognostic value of disease dissemination
2006-01-01 Arcaini, L; Burcheri, S; Rossi, A; Passamonti, Francesco; Paulli, Marco; Boveri, E; Brusamolino, E; Orlandi, E; Molteni, A; Pulsoni, A; Cox, Mc; Orsucci, L; Fabbri, A; Frezzato, M; Voso, Mt; Zaja, F; Montanari, F; Pascutto, C; Morra, E; Cortelazzo, S; Lazzarino, M.
HLA typing and VH gene rearrangement analysis in a family with hairy cell leukaemia
2007-01-01 Rumi, E; Passamonti, Francesco; Zibellini, S; Martinetti, M; Arcaini, L; Elena, C; Cazzola, M; Lazzarino, M.
Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndrome
2009-01-01 Della Porta, Mg; Malcovati, L; Boveri, E; Travaglino, E; Pietra, D; Pascutto, C; Passamonti, Francesco; Invernizzi, R; Castello, A; Magrini, U; Lazzarino, M; Cazzola, M.
JAK2 (V617F) mutation in healthy individuals
2007-01-01 Passamonti, Francesco; Rumi, E; Pietra, D; Lazzarino, M; Cazzola, M.
Combination of rituximab, cyclophosphamide, and vincristine induces complete hematologic remission of splenic marginal zone lymphoma.
2004-01-01 Arcaini, L; Orlandi, E; Scotti, M; Brusamolino, E; Passamonti, Francesco; Burcheri, S; Colombo, N; Vanelli, L; Sbalzarini, G; Lazzarino, M.
Familial chronic myeloproliferative disorders: clinical phenotype and evidence of disease anticipation
2007-01-01 Rumi, E; Passamonti, Francesco; Della Porta, Mg; Elena, C; Arcaini, L; Vanelli, L; Del Curto, C; Pietra, D; Boveri, E; Pascutto, C; Cazzola, M; Lazzarino, M.
A dynamic prognostic model to predict survival in post-polycythemia vera myelofibrosis
2008-01-01 Passamonti, Francesco; Rumi, E; Caramella, M; Elena, C; Arcaini, L; Boveri, E; Del Curto, C; Pietra, D; Vanelli, L; Bernasconi, P; Pascutto, C; Cazzola, M; Morra, E; Lazzarino, M.
Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V>F) mutation
2007-01-01 Passamonti, Francesco; Randi, Ml; Rumi, E; Pungolino, E; Elena, C; Pietra, D; Scapin, M; Arcaini, L; Tezza, F; Moratti, R; Pascutto, C; Fabris, F; Morra, E; Cazzola, M; Lazzarino, M.
Blood p50 evaluation enhances diagnostic definition of isolated erythrocytosis.
2009-01-01 Rumi, E; Passamonti, Francesco; Pagano, L; Ammirabile, M; Arcaini, L; Elena, C; Flagiello, A; Tedesco, R; Vercellati, C; Marcello, Ap; Pietra, D; Moratti, R; Cazzola, M; Lazzarino, M.
Not just clonal expansion of hematopoietic cells, but also activation of their progeny in the pathogenesis of myeloproliferative disorders
2006-01-01 Cazzola, M; Passamonti, Francesco
Muco-cutaneous changes during long-term therapy with hydroxyurea in chronic myeloid leukaemia.
2001-01-01 Vassallo, C.; Passamonti, Francesco; Merante, S.; Ardigò, M.; Nolli, G.; Mangiacavalli, S.; Borroni, G.
Polycythemia vera in young patients: a study on the long-term risk of thrombosis, myelofibrosis and leukemia.
2003-01-01 Passamonti, Francesco; Malabarba, L; Orlandi, E; Baratè, C; Canevari, A; Brusamolino, E; Bonfichi, M; Arcaini, L; Caberlon, S; Pascutto, C; Lazzarino, M.
Pomalidomide is active in the treatment of anemia associated with myelofibrosis
2009-01-01 Tefferi, A; Verstovsek, S; Barosi, G; Passamonti, Francesco; Roboz, Gj; Gisslinger, H; Paquette, Rl; Cervantes, F; Rivera, Ce; Deeg, Hj; Thiele, J; Kvasnicka, Hm; Vardiman, Jw; Zhang, Y; Bekele, Bn; Mesa, Ra; Gale, Rp; Kantarjian, H.
Dyspnea secondary to pulmonary hematopoiesis as presenting symptom of myelofibrosis with myeloid metaplasia
2006-01-01 Rumi, E; Passamonti, Francesco; Boveri, E; De Amici, M; Astori, C; Braschi, M; Castagnola, C; Magrini, U; Cazzola, M; Lazzarino, M.
A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications.
2010-01-01 Passamonti, Francesco; Rumi, E; Pietra, D; Elena, C; Boveri, E; Arcaini, L; Roncoroni, E; Astori, C; Merli, M; Boggi, S; Pascutto, C; Lazzarino, M; Cazzola, M.
Clinical relevance of JAK2 (V617F) mutant allele burden
2009-01-01 Passamonti, Francesco; Rumi, E.
A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)
2010-01-01 Passamonti, Francesco; Cervantes, F; Vannucchi, Am; Morra, E; Rumi, E; Pereira, A; Guglielmelli, P; Pungolino, E; Caramella, M; Maffioli, M; Pascutto, C; Lazzarino, M; Cazzola, M; Tefferi, A.
Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma.
2010-01-01 Zibellini, S; Capello, D; Forconi, F; Marcatili, P; Rossi, D; Rattotti, S; Franceschetti, S; Sozzi, E; Cencini, E; Marasca, R; Baldini, L; Tucci, A; Bertoni, F; Passamonti, Francesco; Orlandi, E; Varettoni, M; Merli, M; Rizzi, S; Gattei, V; Tramontano, A; Paulli, Marco; Gaidano, G; Arcaini, L.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A long-term time course of colorimetric assessment of the effects of imatinib mesylate on skin pigmentation: a study of five patients | 1-gen-2007 | Brazzelli, V; Prestinari, F; Barbagallo, T; Rona, C; Orlandi, E; Passamonti, Francesco; Locatelli, F; Zecca, M; Villani, S; Borroni, G. | |
| Platelet size distinguishes between inherited macrothrombocytopenias and immune thrombocytopenia. | 1-gen-2009 | Noris, P; Klersy, C; Zecca, M; Arcaini, L; Pecci, A; Melazzini, F; Terulla, V; Bozzi, V; Ambaglio, C; Passamonti, Francesco; Locatelli, F; Balduini, C. L. | |
| Nongastric marginal zone B-cell lymphoma of MALT: prognostic value of disease dissemination | 1-gen-2006 | Arcaini, L; Burcheri, S; Rossi, A; Passamonti, Francesco; Paulli, Marco; Boveri, E; Brusamolino, E; Orlandi, E; Molteni, A; Pulsoni, A; Cox, Mc; Orsucci, L; Fabbri, A; Frezzato, M; Voso, Mt; Zaja, F; Montanari, F; Pascutto, C; Morra, E; Cortelazzo, S; Lazzarino, M. | |
| HLA typing and VH gene rearrangement analysis in a family with hairy cell leukaemia | 1-gen-2007 | Rumi, E; Passamonti, Francesco; Zibellini, S; Martinetti, M; Arcaini, L; Elena, C; Cazzola, M; Lazzarino, M. | |
| Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndrome | 1-gen-2009 | Della Porta, Mg; Malcovati, L; Boveri, E; Travaglino, E; Pietra, D; Pascutto, C; Passamonti, Francesco; Invernizzi, R; Castello, A; Magrini, U; Lazzarino, M; Cazzola, M. | |
| JAK2 (V617F) mutation in healthy individuals | 1-gen-2007 | Passamonti, Francesco; Rumi, E; Pietra, D; Lazzarino, M; Cazzola, M. | |
| Combination of rituximab, cyclophosphamide, and vincristine induces complete hematologic remission of splenic marginal zone lymphoma. | 1-gen-2004 | Arcaini, L; Orlandi, E; Scotti, M; Brusamolino, E; Passamonti, Francesco; Burcheri, S; Colombo, N; Vanelli, L; Sbalzarini, G; Lazzarino, M. | |
| Familial chronic myeloproliferative disorders: clinical phenotype and evidence of disease anticipation | 1-gen-2007 | Rumi, E; Passamonti, Francesco; Della Porta, Mg; Elena, C; Arcaini, L; Vanelli, L; Del Curto, C; Pietra, D; Boveri, E; Pascutto, C; Cazzola, M; Lazzarino, M. | |
| A dynamic prognostic model to predict survival in post-polycythemia vera myelofibrosis | 1-gen-2008 | Passamonti, Francesco; Rumi, E; Caramella, M; Elena, C; Arcaini, L; Boveri, E; Del Curto, C; Pietra, D; Vanelli, L; Bernasconi, P; Pascutto, C; Cazzola, M; Morra, E; Lazzarino, M. | |
| Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V>F) mutation | 1-gen-2007 | Passamonti, Francesco; Randi, Ml; Rumi, E; Pungolino, E; Elena, C; Pietra, D; Scapin, M; Arcaini, L; Tezza, F; Moratti, R; Pascutto, C; Fabris, F; Morra, E; Cazzola, M; Lazzarino, M. | |
| Blood p50 evaluation enhances diagnostic definition of isolated erythrocytosis. | 1-gen-2009 | Rumi, E; Passamonti, Francesco; Pagano, L; Ammirabile, M; Arcaini, L; Elena, C; Flagiello, A; Tedesco, R; Vercellati, C; Marcello, Ap; Pietra, D; Moratti, R; Cazzola, M; Lazzarino, M. | |
| Not just clonal expansion of hematopoietic cells, but also activation of their progeny in the pathogenesis of myeloproliferative disorders | 1-gen-2006 | Cazzola, M; Passamonti, Francesco | |
| Muco-cutaneous changes during long-term therapy with hydroxyurea in chronic myeloid leukaemia. | 1-gen-2001 | Vassallo, C.; Passamonti, Francesco; Merante, S.; Ardigò, M.; Nolli, G.; Mangiacavalli, S.; Borroni, G. | |
| Polycythemia vera in young patients: a study on the long-term risk of thrombosis, myelofibrosis and leukemia. | 1-gen-2003 | Passamonti, Francesco; Malabarba, L; Orlandi, E; Baratè, C; Canevari, A; Brusamolino, E; Bonfichi, M; Arcaini, L; Caberlon, S; Pascutto, C; Lazzarino, M. | |
| Pomalidomide is active in the treatment of anemia associated with myelofibrosis | 1-gen-2009 | Tefferi, A; Verstovsek, S; Barosi, G; Passamonti, Francesco; Roboz, Gj; Gisslinger, H; Paquette, Rl; Cervantes, F; Rivera, Ce; Deeg, Hj; Thiele, J; Kvasnicka, Hm; Vardiman, Jw; Zhang, Y; Bekele, Bn; Mesa, Ra; Gale, Rp; Kantarjian, H. | |
| Dyspnea secondary to pulmonary hematopoiesis as presenting symptom of myelofibrosis with myeloid metaplasia | 1-gen-2006 | Rumi, E; Passamonti, Francesco; Boveri, E; De Amici, M; Astori, C; Braschi, M; Castagnola, C; Magrini, U; Cazzola, M; Lazzarino, M. | |
| A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications. | 1-gen-2010 | Passamonti, Francesco; Rumi, E; Pietra, D; Elena, C; Boveri, E; Arcaini, L; Roncoroni, E; Astori, C; Merli, M; Boggi, S; Pascutto, C; Lazzarino, M; Cazzola, M. | |
| Clinical relevance of JAK2 (V617F) mutant allele burden | 1-gen-2009 | Passamonti, Francesco; Rumi, E. | |
| A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment) | 1-gen-2010 | Passamonti, Francesco; Cervantes, F; Vannucchi, Am; Morra, E; Rumi, E; Pereira, A; Guglielmelli, P; Pungolino, E; Caramella, M; Maffioli, M; Pascutto, C; Lazzarino, M; Cazzola, M; Tefferi, A. | |
| Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma. | 1-gen-2010 | Zibellini, S; Capello, D; Forconi, F; Marcatili, P; Rossi, D; Rattotti, S; Franceschetti, S; Sozzi, E; Cencini, E; Marasca, R; Baldini, L; Tucci, A; Bertoni, F; Passamonti, Francesco; Orlandi, E; Varettoni, M; Merli, M; Rizzi, S; Gattei, V; Tramontano, A; Paulli, Marco; Gaidano, G; Arcaini, L. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- Articoli su Riviste35072
Data di pubblicazione
- In corso di stampa25
- 2020 - 202710392
- 2010 - 201911782
- 2000 - 20097850
- 1990 - 19993601
- 1980 - 19891162
- 1970 - 1979252
- 1967 - 19698
Editore
- Edizioni Luigi Pozzi Srl:via Pana...51
- Japadre Editore, L'Aquila36
- WILEY34
- Elsevier BV:PO Box 211, 1000 AE A...31
- ELSEVIER SCIENCE BV29
- Franco Angeli Riviste SRL:viale M...28
- Springer Verlag Germany:Tiergarte...28
- -Roma: [s.n.]. -Artegierre-Esseze...26
- Elsevier B.V.23
- Royal Society of Chemistry:Thomas...21
Rivista
- PHYSICAL REVIEW LETTERS216
- LA RADIOLOGIA MEDICA180
- NUCLEAR INSTRUMENTS & METHODS IN ...176
- ASTRONOMY & ASTROPHYSICS168
- MONTHLY NOTICES OF THE ROYAL ASTR...165
- PHYSICS LETTERS. SECTION B154
- PLOS ONE152
- SCIENTIFIC REPORTS151
- THROMBOSIS AND HAEMOSTASIS145
- IL PROTAGORA140
Serie
- PROCEEDINGS OF INTERNATIONAL MATH...1
Keyword
- Humans1605
- Female801
- Male679
- Middle Aged514
- COVID-19506
- Aged475
- Adult453
- Italy337
- SARS-CoV-2310
- Treatment Outcome237
Lingua
- eng18787
- ita2905
- fre60
- spa55
- ger35
- por14
- bul9
- rus8
- gre6
- chi3
Accesso al fulltext
- no fulltext24541
- reserved5244
- open5084
- restricted107
- partially open93
- mixed2
- embargoed1